Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis

Clinical Neurology and Neurosurgery

Volumn 110, Issue 3, 2008, Pages 233-238

  Rot, Uroš ^a   Ledinek, Alenka Horvat ^a   Jazbec, Saša Šega ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Cerebrospinal fluid; Clinical features; Clinically isolated syndrome; Evoked potentials; MRI; Relapsing remitting multiple sclerosis

Indexed keywords

OLIGOCLONAL BAND;

ADOLESCENT; ADULT; ARTICLE; CEREBELLUM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; ELECTROPHYSIOLOGY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGE OF ONSET; CEREBROSPINAL FLUID; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EVOKED POTENTIALS, SOMATOSENSORY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; LEUKOCYTE COUNT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 39749187446     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.11.001     Document Type: Article

References (25)

1. IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicentre, randomized, double-blind, placebo-controlled trial. Neurology 43 (1993) 655-661
2. Johnson K.P., Brooks B.R., Cohen J.A., Ford C.C., Goldstein J., Lisak R.P., et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicentre, double-blind, placebo-controlled trial. Neurology 45 (1995) 1268-1276
3. Jacobs L., Beck R., Simon J., Kinkel R.P., Brownscheide C.M., Murray T.J., et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 343 (2000) 898-904
4. Comi G., et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357 (2001) 1576-1582
5. Kappos L., et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67 (2006) 1242-1249
6. Motamed M.R., Najimi N., and Fereshtehnejad S.M. The effect of interferon beta-1a on relapses and progression of disability in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis. Clin Neurol Neurosurg 109 (2007) 344-349
7. Filippi M., Rovaris M., Inglese M., Barkhof F., De Stefano N., Smith S., et al. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 1489-1496
8. Mc Donald W., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
9. Kurtzke J. Rating neurological impairment in multiple sclerosis: an expanded disability rating scale. Neurology 38 (1988) 180-185
10. Olsson T., Kostulas V., and Link H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double antibody peroxidase labelling and avidin-biotin amplification. Clin Chem 30 (1984) 1246-1249
11. Brecelj J. Visual evoked potentials and electrophysiological evaluation of the visual pathway. Med Razgl 33 (1994) 339-359
12. Denišlič M., and Prevec T. Analysis of somatosensory evoked potentials in multiple sclerosis. Zdrav Vestn 56 (1987) 7-10
13. Bronnum-Hansen H., Koch-Henriksen N., and Hyllested K. Survival of patients with multiple sclerosis in Denmark: a nationwide long-term epidemiologic survey. Neurology 44 (1994) 1901-1907
14. Weinshenker B.G., Bass B., and Rice G.P.A. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 112 (1989) 133-146
15. Dalton C.M., Brex P.A., Miszkiel K.A., Hickman S.J., MacManus D.G., Plant G.T., et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 52 (2002) 47-53
16. Tintore M., Rovira A., Rio J., Nos C., Grive E., Tellez N., et al. Is optic neuritis more benign than other first attacks in multiple sclerosis?. Ann Neurol 57 (2005) 210-215
17. Rot U., and Mesec A. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis. Clin Neurol Neurosurg 108 (2006) 271-274
18. Tintore M., Rovira A., Rio J., Nos C., Grive E., Sastre-Garriga J., et al. New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode. Neurology 60 (2003) 27-30
19. Dalton C.M., Brex P.S., Miszkiel K.A., Fernando K., MacManus D.G., Plant G.T., et al. Spinal cord MRI in clinically isolated optic neuritis. J Neurol Neurosurg Psychiatry 74 (2003) 1577-1580
20. Sastre-Garriga J., Tintore M., Rovira A., Grive E., Pericot I., Comabella M., et al. Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult Scler 9 (2003) 39-43
21. Soederstroem M., Ya-Ping J., Hillert J., and Link H. Optic neuritis. Prognosis for multiple sclerosis from MRI, CSF and HLA findings. Neurology 50 (1998) 708-714
22. Rolak L.A., Beck R.W., Paty D.W., Tourtellotte W.W., Whitaker J.N., and Rudick R.A. Cerebrospinal fluid in acute optic neuritis: experience from the optic neuritis treatment trial. Neurology 46 (1996) 368-372
23. Rot U., Mesec A., and Pogačnik T. Multiple sclerosis with uncommon cerebrospinal fluid findings. Croat Med J 44 (2003) 697-701
24. Walker R., Thompson E., and McDonald W. Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leukocytes and clinical features. J Neurol 232 (1985) 250-259
25. Cordonnier C., de Seze J., Breteau G., Ferriby D., Michelin E., Stojkovic T., et al. Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol 250 (2003) 1447-1452